Intracellular Therapies
1 known investors
A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.
Founders & leadership
PG
Paul Greengard
Investors · 1
Frequently asked questions
- What does Intracellular Therapies do?
- A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.
- Who founded Intracellular Therapies?
- Intracellular Therapies was founded by Paul Greengard.
- Who are Intracellular Therapies's investors?
- Intracellular Therapies's investors include Scientia Ventures.